{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:25:41Z","timestamp":1787318741981,"version":"build-2736575974"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Applied Basic Research Project of the Department of Science and Technology of Qinghai Province","award":["2022-ZJ-743"],"award-info":[{"award-number":["2022-ZJ-743"]}]},{"name":"Applied Basic Research Project of the Department of Science and Technology of Qinghai Provin","award":["2022-ZJ-743"],"award-info":[{"award-number":["2022-ZJ-743"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    The dysregulation of phosphatidylcholine (PC), triglycerides (TG), phosphatidylethanolamine (PE), and cardiolipin (CL) metabolism is believed to contribute to the development of MASLD. However, little is known about the mechanisms underlying the onset of this condition. To establish a mouse model of MASLD, C57BL\/6J mice were fed a high-fat diet (HFD). Lipidomics was applied to identify differences in liver lipids. RNA-sequencing and bioinformatics analyses were conducted to investigate changes in the expression of genes and pathways associated with these metabolic processes. 49 lipid classes and 3221 lipid species were identified using positive- and negative-ion pattern identification. A total of 678 differentially expressed genes were identified, of which 364 were upregulated and 314 were downregulated in the MASLD group. KEGG enrichment pathway analysis highlighted the downregulation of four genes such as\n                    <jats:italic>Gpat4<\/jats:italic>\n                    ,\n                    <jats:italic>Gpcpd1<\/jats:italic>\n                    ,\n                    <jats:italic>Chkb<\/jats:italic>\n                    , and\n                    <jats:italic>Etnppl.<\/jats:italic>\n                    These findings contribute to our understanding of the metabolic changes associated with MASLD.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0332177","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:27:44Z","timestamp":1762540064000},"page":"e0332177","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-omics analysis reveals metabolic regulation of phosphatidylcholine, triglycerides, phosphatidylethanolamine, and cardiolipin metabolism in mouse liver with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1371","volume":"20","author":[{"given":"Hong","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-9044","authenticated-orcid":true,"given":"Kang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"7","key":"pone.0332177.ref001","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"International Consensus Panel","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0332177.ref002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Z Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"pone.0332177.ref003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission","volume":"5","author":"SK Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"pone.0332177.ref004","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"M Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"pone.0332177.ref005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation","volume":"18","author":"J Zhao","year":"2024","journal-title":"Hepatol Int"},{"issue":"24","key":"pone.0332177.ref006","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","article-title":"Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease","volume":"25","author":"JM Mato","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"pone.0332177.ref007","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of Insulin Resistance in MAFLD","volume":"22","author":"Y Sakurai","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0332177.ref008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China","volume":"107","author":"Y Liang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0332177.ref009","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"J Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"pone.0332177.ref010","doi-asserted-by":"crossref","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"D-Q Sun","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"pone.0332177.ref011","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"T-Y Wang","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"pone.0332177.ref012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.plipres.2011.02.004","article-title":"Mechanisms of glycerophospholipid homeostasis in mammalian cells","volume":"50","author":"M Hermansson","year":"2011","journal-title":"Prog Lipid Res"},{"key":"pone.0332177.ref013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2017.01.002","article-title":"Sphingolipids and glycerophospholipids - The \u201cying and yang\u201d of lipotoxicity in metabolic diseases","volume":"66","author":"S Rodriguez-Cuenca","year":"2017","journal-title":"Prog Lipid Res"},{"key":"pone.0332177.ref014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2020.06.049","article-title":"Advances in lipidomics","volume":"510","author":"HF Avela","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"6","key":"pone.0332177.ref015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"J Araya","year":"2004","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"pone.0332177.ref016","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"P Puri","year":"2007","journal-title":"Hepatology"},{"issue":"17","key":"pone.0332177.ref017","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1073\/pnas.0601752103","article-title":"Evidence for a role of developmental genes in the origin of obesity and body fat distribution","volume":"103","author":"S Gesta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0332177.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.03.055","article-title":"Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease","volume":"605","author":"Y Ma","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"pone.0332177.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267513","article-title":"Comprehensive lipidomic analysis reveals regulation of glyceride metabolism in rat visceral adipose tissue by high-altitude chronic hypoxia","volume":"17","author":"H Liang","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"pone.0332177.ref020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"A Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"6617","key":"pone.0332177.ref021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.ade7614","article-title":"Sex matters in liver fat regulation","volume":"378","author":"DJ Waxman","year":"2022","journal-title":"Science"},{"issue":"22","key":"pone.0332177.ref022","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.3390\/nu14224930","article-title":"Polyphenol-Rich Liupao Tea Extract Prevents High-Fat Diet-Induced MAFLD by Modulating the Gut Microbiota","volume":"14","author":"W Tang","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"pone.0332177.ref023","first-page":"274","article-title":"Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation","volume":"8","author":"Z Zakaria","year":"2021","journal-title":"Vet Sci"},{"issue":"6","key":"pone.0332177.ref024","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jalm\/jfaa044","article-title":"Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis","volume":"5","author":"Y Fujii","year":"2020","journal-title":"J Appl Lab Med"},{"issue":"1","key":"pone.0332177.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"M Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"issue":"956","key":"pone.0332177.ref026","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/pgmj.2004.025601","article-title":"Pathophysiology of dyslipidaemia in the metabolic syndrome","volume":"81","author":"GD Kolovou","year":"2005","journal-title":"Postgrad Med J"},{"key":"pone.0332177.ref027","doi-asserted-by":"crossref","first-page":"176159","DOI":"10.1016\/j.ejphar.2023.176159","article-title":"Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice","volume":"960","author":"D Zhang","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"pone.0332177.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.12.044","article-title":"Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor\/Firsocostat","volume":"21","author":"EJ Lawitz","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0332177.ref029","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tem.2022.03.005","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease","volume":"33","author":"JS Moon","year":"2022","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"pone.0332177.ref030","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.3390\/ijms25052961","article-title":"Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease","volume":"25","author":"M Soto-Catal\u00e1n","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0332177.ref031","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbalip.2008.10.010","article-title":"Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis","volume":"1791","author":"AA Wendel","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"pone.0332177.ref032","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"C Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0332177.ref033","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"F Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"pone.0332177.ref034","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","article-title":"Phosphatidylethanolamine Metabolism in Health and Disease","volume":"321","author":"E Calzada","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"issue":"5","key":"pone.0332177.ref035","doi-asserted-by":"crossref","first-page":"939","DOI":"10.14218\/JCTH.2022.00067","article-title":"Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD","volume":"10","author":"K Clare","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"pone.0332177.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tra.12230","article-title":"Phospholipid synthesis and transport in mammalian cells","volume":"16","author":"JE Vance","year":"2015","journal-title":"Traffic"},{"issue":"6","key":"pone.0332177.ref037","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","article-title":"Phosphatidylethanolamine deficiency in Mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology","volume":"288","author":"G Tasseva","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0332177.ref038","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.freeradbiomed.2023.02.017","article-title":"ETNPPL impairs autophagy through regulation of the ARG2-ROS signaling axis, contributing to palmitic acid-induced hepatic insulin resistance","volume":"199","author":"C Wang","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"pone.0332177.ref039","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3390\/ijms14022529","article-title":"Regulation of Phosphatidylethanolamine Homeostasis\u2014The Critical Role of CTP:Phosphoethanolamine Cytidylyltransferase (Pcyt2)","volume":"14","author":"Z Pavlovic","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0332177.ref040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jclinpath-2015-203042","article-title":"AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis","volume":"69","author":"Q Ding","year":"2016","journal-title":"J Clin Pathol"},{"issue":"45","key":"pone.0332177.ref041","doi-asserted-by":"crossref","first-page":"37798","DOI":"10.1074\/jbc.M508575200","article-title":"Phosphatidylcholine homeostasis and liver failure","volume":"280","author":"Z Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"pone.0332177.ref042","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1194\/jlr.M800660-JLR200","article-title":"Depletion of phosphatidylcholine affects endoplasmic reticulum morphology and protein traffic at the Golgi complex","volume":"50","author":"N Testerink","year":"2009","journal-title":"J Lipid Res"},{"issue":"4","key":"pone.0332177.ref043","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cell.2011.09.045","article-title":"A conserved SREBP-1\/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans","volume":"147","author":"AK Walker","year":"2011","journal-title":"Cell"},{"issue":"5","key":"pone.0332177.ref044","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jcmgh.2024.01.009","article-title":"Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL\/6J Mice","volume":"17","author":"V S\u00e1nchez","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"23","key":"pone.0332177.ref045","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/j.jmb.2020.09.022","article-title":"Emergent Coordination of the CHKB and CPT1B Genes in Eutherian Mammals: Implications for the Origin of Brown Adipose Tissue","volume":"432","author":"BV Patel","year":"2020","journal-title":"J Mol Biol"},{"issue":"1","key":"pone.0332177.ref046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13395-022-00306-8","article-title":"Megaconial congenital muscular dystrophy due to novel CHKB variants: a case report and literature review","volume":"12","author":"F Magri","year":"2022","journal-title":"Skelet Muscle"},{"issue":"4","key":"pone.0332177.ref047","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"G Paradies","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"39","key":"pone.0332177.ref048","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"G Paradies","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"10","key":"pone.0332177.ref049","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bbabio.2007.07.011","article-title":"Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin","volume":"1767","author":"G Petrosillo","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"pone.0332177.ref050","article-title":"Systems Analyses Reveal Physiological Roles and Genetic Regulators of Liver Lipid Species","volume":"6","author":"P Jha","year":"2018","journal-title":"Cell Syst"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:27:54Z","timestamp":1762540074000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332177"}},"subtitle":[],"editor":[{"given":"Amr Ahmed","family":"El-Arabey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332177","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]}}}